img

Global Plasma Protein Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Plasma Protein Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
Plasma Protein Therapeutics report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Plasma Protein Therapeutics market is projected to reach US$ 44730 million in 2034, increasing from US$ 28070 million in 2022, with the CAGR of 6.8% during the period of 2024 to 2034. Demand from Hemophilia and PID are the major drivers for the industry.
Shire (Baxalta), CSL and Grifolsare the leaders of the Plasma Protein Therapeutics industry, which take about 55% market share. China is the major region of the global market, which takes about 45% market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Plasma Protein Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Kamada
Segment by Type
Coagulation Factor
Immune Globulin
Albumin
Others

Segment by Application


Hemophilia
PID
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Plasma Protein Therapeutics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Plasma Protein Therapeutics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Plasma Protein Therapeutics industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Plasma Protein Therapeutics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Plasma Protein Therapeutics introduction, etc. Plasma Protein Therapeutics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Plasma Protein Therapeutics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Plasma Protein Therapeutics Market Overview
1.1 Plasma Protein Therapeutics Product Overview
1.2 Plasma Protein Therapeutics Market Segment by Type
1.2.1 Coagulation Factor
1.2.2 Immune Globulin
1.2.3 Albumin
1.2.4 Others
1.3 Global Plasma Protein Therapeutics Market Size by Type
1.3.1 Global Plasma Protein Therapeutics Market Size Overview by Type (2018-2034)
1.3.2 Global Plasma Protein Therapeutics Historic Market Size Review by Type (2018-2024)
1.3.3 Global Plasma Protein Therapeutics Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Plasma Protein Therapeutics Sales Breakdown by Type (2018-2024)
1.4.2 Europe Plasma Protein Therapeutics Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Plasma Protein Therapeutics Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Plasma Protein Therapeutics Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Plasma Protein Therapeutics Sales Breakdown by Type (2018-2024)
2 Global Plasma Protein Therapeutics Market Competition by Company
2.1 Global Top Players by Plasma Protein Therapeutics Sales (2018-2024)
2.2 Global Top Players by Plasma Protein Therapeutics Revenue (2018-2024)
2.3 Global Top Players by Plasma Protein Therapeutics Price (2018-2024)
2.4 Global Top Manufacturers Plasma Protein Therapeutics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Plasma Protein Therapeutics Market Competitive Situation and Trends
2.5.1 Plasma Protein Therapeutics Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Plasma Protein Therapeutics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Plasma Protein Therapeutics as of 2022)
2.7 Date of Key Manufacturers Enter into Plasma Protein Therapeutics Market
2.8 Key Manufacturers Plasma Protein Therapeutics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Plasma Protein Therapeutics Status and Outlook by Region
3.1 Global Plasma Protein Therapeutics Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Plasma Protein Therapeutics Historic Market Size by Region
3.2.1 Global Plasma Protein Therapeutics Sales in Volume by Region (2018-2024)
3.2.2 Global Plasma Protein Therapeutics Sales in Value by Region (2018-2024)
3.2.3 Global Plasma Protein Therapeutics Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Plasma Protein Therapeutics Forecasted Market Size by Region
3.3.1 Global Plasma Protein Therapeutics Sales in Volume by Region (2024-2034)
3.3.2 Global Plasma Protein Therapeutics Sales in Value by Region (2024-2034)
3.3.3 Global Plasma Protein Therapeutics Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Plasma Protein Therapeutics by Application
4.1 Plasma Protein Therapeutics Market Segment by Application
4.1.1 Hemophilia
4.1.2 PID
4.1.3 Others
4.2 Global Plasma Protein Therapeutics Market Size by Application
4.2.1 Global Plasma Protein Therapeutics Market Size Overview by Application (2018-2034)
4.2.2 Global Plasma Protein Therapeutics Historic Market Size Review by Application (2018-2024)
4.2.3 Global Plasma Protein Therapeutics Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Plasma Protein Therapeutics Sales Breakdown by Application (2018-2024)
4.3.2 Europe Plasma Protein Therapeutics Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Plasma Protein Therapeutics Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Plasma Protein Therapeutics Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Plasma Protein Therapeutics Sales Breakdown by Application (2018-2024)
5 North America Plasma Protein Therapeutics by Country
5.1 North America Plasma Protein Therapeutics Historic Market Size by Country
5.1.1 North America Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Plasma Protein Therapeutics Sales in Volume by Country (2018-2024)
5.1.3 North America Plasma Protein Therapeutics Sales in Value by Country (2018-2024)
5.2 North America Plasma Protein Therapeutics Forecasted Market Size by Country
5.2.1 North America Plasma Protein Therapeutics Sales in Volume by Country (2024-2034)
5.2.2 North America Plasma Protein Therapeutics Sales in Value by Country (2024-2034)
6 Europe Plasma Protein Therapeutics by Country
6.1 Europe Plasma Protein Therapeutics Historic Market Size by Country
6.1.1 Europe Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Plasma Protein Therapeutics Sales in Volume by Country (2018-2024)
6.1.3 Europe Plasma Protein Therapeutics Sales in Value by Country (2018-2024)
6.2 Europe Plasma Protein Therapeutics Forecasted Market Size by Country
6.2.1 Europe Plasma Protein Therapeutics Sales in Volume by Country (2024-2034)
6.2.2 Europe Plasma Protein Therapeutics Sales in Value by Country (2024-2034)
7 Asia-Pacific Plasma Protein Therapeutics by Region
7.1 Asia-Pacific Plasma Protein Therapeutics Historic Market Size by Region
7.1.1 Asia-Pacific Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Plasma Protein Therapeutics Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Plasma Protein Therapeutics Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Plasma Protein Therapeutics Forecasted Market Size by Region
7.2.1 Asia-Pacific Plasma Protein Therapeutics Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Plasma Protein Therapeutics Sales in Value by Region (2024-2034)
8 Latin America Plasma Protein Therapeutics by Country
8.1 Latin America Plasma Protein Therapeutics Historic Market Size by Country
8.1.1 Latin America Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Plasma Protein Therapeutics Sales in Volume by Country (2018-2024)
8.1.3 Latin America Plasma Protein Therapeutics Sales in Value by Country (2018-2024)
8.2 Latin America Plasma Protein Therapeutics Forecasted Market Size by Country
8.2.1 Latin America Plasma Protein Therapeutics Sales in Volume by Country (2024-2034)
8.2.2 Latin America Plasma Protein Therapeutics Sales in Value by Country (2024-2034)
9 Middle East and Africa Plasma Protein Therapeutics by Country
9.1 Middle East and Africa Plasma Protein Therapeutics Historic Market Size by Country
9.1.1 Middle East and Africa Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Plasma Protein Therapeutics Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Plasma Protein Therapeutics Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Plasma Protein Therapeutics Forecasted Market Size by Country
9.2.1 Middle East and Africa Plasma Protein Therapeutics Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Plasma Protein Therapeutics Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Shire (Baxalta)
10.1.1 Shire (Baxalta) Company Information
10.1.2 Shire (Baxalta) Introduction and Business Overview
10.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Shire (Baxalta) Plasma Protein Therapeutics Products Offered
10.1.5 Shire (Baxalta) Recent Development
10.2 CSL
10.2.1 CSL Company Information
10.2.2 CSL Introduction and Business Overview
10.2.3 CSL Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.2.4 CSL Plasma Protein Therapeutics Products Offered
10.2.5 CSL Recent Development
10.3 Grifols
10.3.1 Grifols Company Information
10.3.2 Grifols Introduction and Business Overview
10.3.3 Grifols Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Grifols Plasma Protein Therapeutics Products Offered
10.3.5 Grifols Recent Development
10.4 Octapharma
10.4.1 Octapharma Company Information
10.4.2 Octapharma Introduction and Business Overview
10.4.3 Octapharma Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Octapharma Plasma Protein Therapeutics Products Offered
10.4.5 Octapharma Recent Development
10.5 Kedrion
10.5.1 Kedrion Company Information
10.5.2 Kedrion Introduction and Business Overview
10.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Kedrion Plasma Protein Therapeutics Products Offered
10.5.5 Kedrion Recent Development
10.6 LFB Group
10.6.1 LFB Group Company Information
10.6.2 LFB Group Introduction and Business Overview
10.6.3 LFB Group Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.6.4 LFB Group Plasma Protein Therapeutics Products Offered
10.6.5 LFB Group Recent Development
10.7 Biotest
10.7.1 Biotest Company Information
10.7.2 Biotest Introduction and Business Overview
10.7.3 Biotest Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Biotest Plasma Protein Therapeutics Products Offered
10.7.5 Biotest Recent Development
10.8 BPL
10.8.1 BPL Company Information
10.8.2 BPL Introduction and Business Overview
10.8.3 BPL Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.8.4 BPL Plasma Protein Therapeutics Products Offered
10.8.5 BPL Recent Development
10.9 RAAS
10.9.1 RAAS Company Information
10.9.2 RAAS Introduction and Business Overview
10.9.3 RAAS Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.9.4 RAAS Plasma Protein Therapeutics Products Offered
10.9.5 RAAS Recent Development
10.10 CBPO
10.10.1 CBPO Company Information
10.10.2 CBPO Introduction and Business Overview
10.10.3 CBPO Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.10.4 CBPO Plasma Protein Therapeutics Products Offered
10.10.5 CBPO Recent Development
10.11 Hualan Bio
10.11.1 Hualan Bio Company Information
10.11.2 Hualan Bio Introduction and Business Overview
10.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Hualan Bio Plasma Protein Therapeutics Products Offered
10.11.5 Hualan Bio Recent Development
10.12 Kamada
10.12.1 Kamada Company Information
10.12.2 Kamada Introduction and Business Overview
10.12.3 Kamada Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Kamada Plasma Protein Therapeutics Products Offered
10.12.5 Kamada Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Plasma Protein Therapeutics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Plasma Protein Therapeutics Industrial Chain Analysis
11.4 Plasma Protein Therapeutics Market Dynamics
11.4.1 Plasma Protein Therapeutics Industry Trends
11.4.2 Plasma Protein Therapeutics Market Drivers
11.4.3 Plasma Protein Therapeutics Market Challenges
11.4.4 Plasma Protein Therapeutics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Plasma Protein Therapeutics Distributors
12.3 Plasma Protein Therapeutics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Coagulation Factor
Table 2. Major Company of Immune Globulin
Table 3. Major Company of Albumin
Table 4. Major Company of Others
Table 5. Global Plasma Protein Therapeutics Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Plasma Protein Therapeutics Sales by Type (2018-2024) & (K Units)
Table 7. Global Plasma Protein Therapeutics Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Plasma Protein Therapeutics Sales by Type (2018-2024) & (US& Million)
Table 9. Global Plasma Protein Therapeutics Market Share in Value by Type (2018-2024)
Table 10. Global Plasma Protein Therapeutics Price by Type (2018-2024) & (USD/Unit)
Table 11. Global Plasma Protein Therapeutics Sales by Type (2024-2034) & (K Units)
Table 12. Global Plasma Protein Therapeutics Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Plasma Protein Therapeutics Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Plasma Protein Therapeutics Sales Market Share in Value by Type (2024-2034)
Table 15. Global Plasma Protein Therapeutics Price by Type (2024-2034) & (USD/Unit)
Table 16. North America Plasma Protein Therapeutics Sales by Type (2018-2024) & (K Units)
Table 17. North America Plasma Protein Therapeutics Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Plasma Protein Therapeutics Sales (K Units) by Type (2018-2024)
Table 19. Europe Plasma Protein Therapeutics Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Plasma Protein Therapeutics Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Plasma Protein Therapeutics Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Plasma Protein Therapeutics Sales (K Units) by Type (2018-2024)
Table 23. Latin America Plasma Protein Therapeutics Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Plasma Protein Therapeutics Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Plasma Protein Therapeutics Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Plasma Protein Therapeutics Sales by Company (2018-2024) & (K Units)
Table 27. Global Plasma Protein Therapeutics Sales Share by Company (2018-2024)
Table 28. Global Plasma Protein Therapeutics Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Plasma Protein Therapeutics Revenue Share by Company (2018-2024)
Table 30. Global Market Plasma Protein Therapeutics Price by Company (2018-2024) & (USD/Unit)
Table 31. Global Plasma Protein Therapeutics Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Plasma Protein Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Plasma Protein Therapeutics as of 2022)
Table 34. Date of Key Manufacturers Enter into Plasma Protein Therapeutics Market
Table 35. Key Manufacturers Plasma Protein Therapeutics Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Plasma Protein Therapeutics Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Plasma Protein Therapeutics Sales by Region (2018-2024) & (K Units)
Table 39. Global Plasma Protein Therapeutics Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Plasma Protein Therapeutics Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Plasma Protein Therapeutics Sales Market Share in Value by Region (2018-2024)
Table 42. Global Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 43. Global Plasma Protein Therapeutics Sales by Region (2024-2034) & (K Units)
Table 44. Global Plasma Protein Therapeutics Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Plasma Protein Therapeutics Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Plasma Protein Therapeutics Sales Market Share in Value by Region (2024-2034)
Table 47. Global Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global Plasma Protein Therapeutics Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Plasma Protein Therapeutics Sales by Application (2018-2024) & (K Units)
Table 50. Global Plasma Protein Therapeutics Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Plasma Protein Therapeutics Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Plasma Protein Therapeutics Sales Market Share in Value by Application (2018-2024)
Table 53. Global Plasma Protein Therapeutics Price by Application (2018-2024) & (USD/Unit)
Table 54. Global Plasma Protein Therapeutics Sales by Application (2024-2034) & (K Units)
Table 55. Global Plasma Protein Therapeutics Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Plasma Protein Therapeutics Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Plasma Protein Therapeutics Sales Market Share in Value by Application (2024-2034)
Table 58. Global Plasma Protein Therapeutics Price by Application (2024-2034) & (USD/Unit)
Table 59. North America Plasma Protein Therapeutics Sales by Application (2018-2024) (K Units)
Table 60. North America Plasma Protein Therapeutics Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Plasma Protein Therapeutics Sales by Application (2018-2024) (K Units)
Table 62. Europe Plasma Protein Therapeutics Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Plasma Protein Therapeutics Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Plasma Protein Therapeutics Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Plasma Protein Therapeutics Sales by Application (2018-2024) (K Units)
Table 66. Latin America Plasma Protein Therapeutics Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Plasma Protein Therapeutics Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Plasma Protein Therapeutics Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Plasma Protein Therapeutics Sales by Country (2018-2024) & (K Units)
Table 70. North America Plasma Protein Therapeutics Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Plasma Protein Therapeutics Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Plasma Protein Therapeutics Sales Market Share in Value by Country (2018-2024)
Table 73. North America Plasma Protein Therapeutics Sales by Country (2024-2034) & (K Units)
Table 74. North America Plasma Protein Therapeutics Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Plasma Protein Therapeutics Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Plasma Protein Therapeutics Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Plasma Protein Therapeutics Sales by Country (2018-2024) & (K Units)
Table 78. Europe Plasma Protein Therapeutics Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Plasma Protein Therapeutics Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Plasma Protein Therapeutics Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Plasma Protein Therapeutics Sales by Country (2024-2034) & (K Units)
Table 82. Europe Plasma Protein Therapeutics Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Plasma Protein Therapeutics Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Plasma Protein Therapeutics Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Plasma Protein Therapeutics Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Plasma Protein Therapeutics Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Plasma Protein Therapeutics Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Plasma Protein Therapeutics Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Plasma Protein Therapeutics Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Plasma Protein Therapeutics Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Plasma Protein Therapeutics Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Plasma Protein Therapeutics Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Plasma Protein Therapeutics Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Plasma Protein Therapeutics Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Plasma Protein Therapeutics Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Plasma Protein Therapeutics Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Plasma Protein Therapeutics Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Plasma Protein Therapeutics Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Plasma Protein Therapeutics Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Plasma Protein Therapeutics Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Plasma Protein Therapeutics Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Plasma Protein Therapeutics Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Plasma Protein Therapeutics Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Plasma Protein Therapeutics Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Plasma Protein Therapeutics Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Plasma Protein Therapeutics Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Plasma Protein Therapeutics Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Plasma Protein Therapeutics Sales Market Share in Value by Country (2024-2034)
Table 109. Shire (Baxalta) Company Information
Table 110. Shire (Baxalta) Introduction and Business Overview
Table 111. Shire (Baxalta) Plasma Protein Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Shire (Baxalta) Plasma Protein Therapeutics Product
Table 113. Shire (Baxalta) Recent Development
Table 114. CSL Company Information
Table 115. CSL Introduction and Business Overview
Table 116. CSL Plasma Protein Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. CSL Plasma Protein Therapeutics Product
Table 118. CSL Recent Development
Table 119. Grifols Company Information
Table 120. Grifols Introduction and Business Overview
Table 121. Grifols Plasma Protein Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Grifols Plasma Protein Therapeutics Product
Table 123. Grifols Recent Development
Table 124. Octapharma Company Information
Table 125. Octapharma Introduction and Business Overview
Table 126. Octapharma Plasma Protein Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Octapharma Plasma Protein Therapeutics Product
Table 128. Octapharma Recent Development
Table 129. Kedrion Company Information
Table 130. Kedrion Introduction and Business Overview
Table 131. Kedrion Plasma Protein Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Kedrion Plasma Protein Therapeutics Product
Table 133. Kedrion Recent Development
Table 134. LFB Group Company Information
Table 135. LFB Group Introduction and Business Overview
Table 136. LFB Group Plasma Protein Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. LFB Group Plasma Protein Therapeutics Product
Table 138. LFB Group Recent Development
Table 139. Biotest Company Information
Table 140. Biotest Introduction and Business Overview
Table 141. Biotest Plasma Protein Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Biotest Plasma Protein Therapeutics Product
Table 143. Biotest Recent Development
Table 144. BPL Company Information
Table 145. BPL Introduction and Business Overview
Table 146. BPL Plasma Protein Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. BPL Plasma Protein Therapeutics Product
Table 148. BPL Recent Development
Table 149. RAAS Company Information
Table 150. RAAS Introduction and Business Overview
Table 151. RAAS Plasma Protein Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 152. RAAS Plasma Protein Therapeutics Product
Table 153. RAAS Recent Development
Table 154. CBPO Company Information
Table 155. CBPO Introduction and Business Overview
Table 156. CBPO Plasma Protein Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 157. CBPO Plasma Protein Therapeutics Product
Table 158. CBPO Recent Development
Table 159. Hualan Bio Company Information
Table 160. Hualan Bio Introduction and Business Overview
Table 161. Hualan Bio Plasma Protein Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 162. Hualan Bio Plasma Protein Therapeutics Product
Table 163. Hualan Bio Recent Development
Table 164. Kamada Company Information
Table 165. Kamada Introduction and Business Overview
Table 166. Kamada Plasma Protein Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 167. Kamada Plasma Protein Therapeutics Product
Table 168. Kamada Recent Development
Table 169. Key Raw Materials Lists
Table 170. Raw Materials Key Suppliers Lists
Table 171. Plasma Protein Therapeutics Market Trends
Table 172. Plasma Protein Therapeutics Market Drivers
Table 173. Plasma Protein Therapeutics Market Challenges
Table 174. Plasma Protein Therapeutics Market Restraints
Table 175. Plasma Protein Therapeutics Distributors List
Table 176. Plasma Protein Therapeutics Downstream Customers
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Plasma Protein Therapeutics Product Picture
Figure 2. Global Plasma Protein Therapeutics Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Plasma Protein Therapeutics Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Plasma Protein Therapeutics Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Coagulation Factor
Figure 6. Global Coagulation Factor Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Immune Globulin
Figure 8. Global Immune Globulin Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Albumin
Figure 10. Global Albumin Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Global Plasma Protein Therapeutics Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Plasma Protein Therapeutics Sales Market Share by Type in 2022 & 2034
Figure 15. North America Plasma Protein Therapeutics Sales Market Share in Volume by Type in 2022
Figure 16. North America Plasma Protein Therapeutics Sales Market Share in Value by Type in 2022
Figure 17. Europe Plasma Protein Therapeutics Sales Market Share in Volume by Type in 2022
Figure 18. Europe Plasma Protein Therapeutics Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Plasma Protein Therapeutics Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Plasma Protein Therapeutics Sales Market Share in Value by Type in 2022
Figure 21. Latin America Plasma Protein Therapeutics Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Plasma Protein Therapeutics Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Plasma Protein Therapeutics Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Plasma Protein Therapeutics Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Plasma Protein Therapeutics Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Plasma Protein Therapeutics Revenue in 2022
Figure 27. Plasma Protein Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hemophilia
Figure 29. Global Hemophilia Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of PID
Figure 31. Global PID Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Global Plasma Protein Therapeutics Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Plasma Protein Therapeutics Sales Market Share by Application in 2022 & 2034
Figure 36. North America Plasma Protein Therapeutics Sales Market Share in Volume by Application in 2022
Figure 37. North America Plasma Protein Therapeutics Sales Market Share in Value by Application in 2022
Figure 38. Europe Plasma Protein Therapeutics Sales Market Share in Volume by Application in 2022
Figure 39. Europe Plasma Protein Therapeutics Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Plasma Protein Therapeutics Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Plasma Protein Therapeutics Sales Market Share in Value by Application in 2022
Figure 42. Latin America Plasma Protein Therapeutics Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Plasma Protein Therapeutics Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Plasma Protein Therapeutics Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Plasma Protein Therapeutics Manufacturing Cost Structure
Figure 47. Plasma Protein Therapeutics Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed